Immunotherapy is a therapy recognized and applied in a complementary way to conventional therapies, but it plays a marginal role in the context of official anti-cancer therapies.
Consequently, its real use in most of the public hospitals is very limited.
The ways in which you may be able to get an immune activation may be different, but in all cases, the principle that underlies it, namely strengthening the body's natural defenses, can be crucial for cancer patients.
The activation of an immune response, in addition to acting directly on the disease, may serve as a support for the organism that is debilitated and immuno suppressed by the evolution of the tumor.
Therefore, immunotherapy finds its logical place as a cancer treatment that is an adjunctive therapy to the official treatments.
The effectiveness of the immune response will be proportional to the resources available to the body.
This means that when the disease is very advanced, and the body has had too many cycles of chemotherapy, radiotherapy or following major surgery, it is very difficult to hope for immune activation.
Therefore the patient is advised to take these immunological therapies concurrently or even in advance to those officers.
In some types of cancers particularly aggressive or in advanced stages, when cure is not achievable, immunological therapies alongside traditional ones, can help to prolong survival and improve quality of life of the patient.
We will report 4 different sources that deal with Cancer Immunotherapy.
1) Already in 2004, at the University Hospital of Siena, has arisen a new "Division of Cancer Immuno therapy".
The program activities of the Unit, as part of the overall management of cancer patients, both with regard to the diagnostic picture that therapy, in addition to conventional chemotherapy treatments currently available and proven, provides a strong commitment to clinical research.
The activity program is therefore designed to make available to the various unit which refer patients to the latest drug therapies and immunological.
To this end, several protocols are already active medical therapy in collaboration with leading cancer institutions, national and foreign.
The new mode of therapy based on biological and immunological characterization of biomolecular tumors of each individual patient are carried out in order to customize as much as possible therapeutic intervention.
2) A medical oncologist named Joseph Zora, in 1975, hampered by all upstream and began a series of experiments in vitro and in vivo immunological test lines.
In 1982 he began to distribute his product, a hybrid organic harmless, non-toxic which allowed a broad spectrum of immune modulation.
Since that date, for about ten years, Dr.
Zora was persecuted at the judicial level.
Then in 1992, his nightmare was over, having registered their product (Plus Adjuvant) in Switzerland as a medicinal product.
Tens of thousands of patients in Italy and throughout Europe and America use it with excellent results.
The action of homeopathic drugs immune type - organic "Adjuvant Plus" Dr Zora performs a dual role: an anti-cancer activity which is carried out by activating the patient's immune system and support action aimed at limiting the immuno suppressive chemotherapy drugs damage.
So it is particularly suitable as adjuvant chemotherapy.
The therapy can also be associated with a multi-therapy treatment Bella.
The treatment consists of intramuscular ampoules, whose dosage and administration should be tailored to the characteristics of each patient.
3) The "Sinterapia" is customized by immunological activation BCG vaccine.
This therapy consists of injections performed in IEL times and dilutions tailored to the immunological responsiveness of the patient and monitored with blood tests and clinic visits.
BCG vaccine is the vaccine commonly used to prevent tuberculosis (Bacillus of Calmette and Guerin) and used in conjunction (indomethacin, an anti-inflammatory) can enhance the body's natural defenses.
The patient should undergo these injections before and after each cycle of chemotherapy, radiotherapy, hormone therapy or surgery.
Through an examination of lymphocyte sub populations, which can be performed free of charge only in a few specialized centers, the doctor can tell in advance whether the patient's weakened body (from disease and by cytotoxic chemotherapy), has still the possibility to trigger a sufficient immune response to fight cancer.
The physician prescribing individualized treatment and follows the trend is Professor Xavier Imperato.
The professor has three free lectures: immunology, general pathology and microbiology and care for about thirty years successfully with cancer.
The cost of treatment is accessible to all.
4) As early as 1921, Rudolf Steiner, German philosopher and physician, found in mistletoe an effective anticancer remedy.
At the clinic Lukas Klinik in Switzerland, in the 80's since the preparations of mistletoe have been subjected to classical scientific inquiry.
The mechanism of action is as follows: the mistletoe lectin contains substances that have the ability to bind to tumor cells and stimulate immune system cells to destroy them.
In an article published in the journal "Oncology" of 1986 is already explained that twenty-four hours after administration of mistletoe we note an increase in the number and activity of natural killer lymphocytes, increased levels of tumor necrosis factor, interleukin, and the activity of macrophages.